Prion-driven evolution

The yeast protein Sup35 is essential for translation termination, but its prion [PSI+] form reduces the fidelity of the termination process. Conversion of Sup35 into the prion form could therefore alter the sequence of multiple proteins at the same time, perhaps providing an engine for evolutionary change. In the 28 September Nature, True and Lindquist find that in nearly half of a long list of culture conditions tested, the presence of [PSI+] exerted a substantial effect on strain growth (Natur

By | October 6, 2000

The yeast protein Sup35 is essential for translation termination, but its prion [PSI+] form reduces the fidelity of the termination process. Conversion of Sup35 into the prion form could therefore alter the sequence of multiple proteins at the same time, perhaps providing an engine for evolutionary change. In the 28 September Nature, True and Lindquist find that in nearly half of a long list of culture conditions tested, the presence of [PSI+] exerted a substantial effect on strain growth (Nature 2000, 407:477-483). In more than 25% of the tests the effect was positive. True and Lindquist suggest that [PSI+] can facilitate the evolution of new traits by converting previously neutral genetic variation to a non-neutral state. In an accompanying News and Views (Nature 2000, 407:457-458), Partridge and Barton do not dispute the data, but do disagree with its interpretation. They propose that the variability is a side-effect of disrupted gene expression, not an adaptation to facilitate evolution.

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech